HNMVX
Price
$32.06
Change
+$0.15 (+0.47%)
Updated
Jun 2 closing price
Net Assets
434.41M
JVMAX
Price
$27.58
Change
+$0.25 (+0.91%)
Updated
Jun 2 closing price
Net Assets
22.67B
Interact to see
Advertisement

HNMVX vs JVMAX

Header iconHNMVX vs JVMAX Comparison
Open Charts HNMVX vs JVMAXBanner chart's image
HNMVX vs JVMAX Comparison Chart in %
View a ticker or compare two or three
VS
HNMVX vs. JVMAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNMVX is a StrongBuy and JVMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMAX has more cash in the bank: 22.7B vs. HNMVX (434M). HNMVX pays higher dividends than JVMAX: HNMVX (1.21) vs JVMAX (0.52). HNMVX was incepted earlier than JVMAX: HNMVX (10 years) vs JVMAX (29 years). JVMAX (1.11) is less costly to investors than HNMVX (0.82). JVMAX is a more actively managed with annual turnover of: 49.00 vs. HNMVX (20.00). JVMAX has a lower initial minimum investment than HNMVX: JVMAX (1000) vs HNMVX (1000000). HNMVX annual gain was more profitable for investors over the last year : 27.06 vs. JVMAX (6.26). HNMVX return over 5 years is better than : 29.59 vs. JVMAX (1.76).
HNMVXJVMAXHNMVX / JVMAX
Total Expense Ratio0.771.1070%
Annual Report Gross Expense Ratio0.821.1174%
Fund Existence10 years29 years-
Gain YTD16.1636.054267%
Front LoadN/A5%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets434M22.7B2%
Annual Yield % from dividends1.210.52234%
Returns for 1 year27.066.26432%
Returns for 3 years48.5317.71274%
Returns for 5 years29.591.761,677%
Returns for 10 years81.0647.00172%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGTX1.340.09
+7.20%
Cognition Therapeutics
VIV13.490.30
+2.27%
Telefonica Brasil SA
CHEF77.680.71
+0.92%
Chefs' Warehouse (The)
BBOT8.24-0.31
-3.63%
BridgeBio Oncology Therapeutics Inc
APVO5.02-0.22
-4.20%
Aptevo Therapeutics Inc